These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26584803)

  • 21. Prediction of protein disorder on amino acid substitutions.
    Anoosha P; Sakthivel R; Gromiha MM
    Anal Biochem; 2015 Dec; 491():18-22. PubMed ID: 26348538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification and characterization of fourth FAS1 domain of TGFβIp-associated corneal dystrophic mutants.
    Elavazhagan M; Lakshminarayanan R; Zhou L; Ting LW; Tong L; Beuerman RW; Chaurasia SS; Mehta JS
    Protein Expr Purif; 2012 Jul; 84(1):108-15. PubMed ID: 22575305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
    Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
    Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies.
    Boncoraglio A; Minoia M; Carra S
    Int J Biochem Cell Biol; 2012 Oct; 44(10):1657-69. PubMed ID: 22484489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compensated pathogenic deviations: analysis of structural effects.
    Baresić A; Hopcroft LE; Rogers HH; Hurst JM; Martin AC
    J Mol Biol; 2010 Feb; 396(1):19-30. PubMed ID: 19900462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.
    Kerman A; Liu HN; Croul S; Bilbao J; Rogaeva E; Zinman L; Robertson J; Chakrabartty A
    Acta Neuropathol; 2010 Mar; 119(3):335-44. PubMed ID: 20111867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods.
    Thusberg J; Vihinen M
    Hum Mutat; 2009 May; 30(5):703-14. PubMed ID: 19267389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three novel GJA1 missense substitutions resulting in oculo-dento-digital dysplasia (ODDD) - further extension of the mutational spectrum.
    Jamsheer A; Sowińska-Seidler A; Socha M; Stembalska A; Kiraly-Borri C; Latos-Bieleńska A
    Gene; 2014 Apr; 539(1):157-61. PubMed ID: 24508941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational Stability and Pathogenic Misfolding of the Integral Membrane Protein PMP22.
    Schlebach JP; Narayan M; Alford C; Mittendorf KF; Carter BD; Li J; Sanders CR
    J Am Chem Soc; 2015 Jul; 137(27):8758-68. PubMed ID: 26102530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NALP3 inflammasome activation in protein misfolding diseases.
    Shi F; Kouadir M; Yang Y
    Life Sci; 2015 Aug; 135():9-14. PubMed ID: 26037399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 diabetes as a protein misfolding disease.
    Mukherjee A; Morales-Scheihing D; Butler PC; Soto C
    Trends Mol Med; 2015 Jul; 21(7):439-49. PubMed ID: 25998900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional impact of missense mutations in TPMT: An integrated computational approach.
    Fazel-Najafabadi E; Vahdat Ahar E; Fattahpour S; Sedghi M
    Comput Biol Chem; 2015 Dec; 59 Pt A():48-55. PubMed ID: 26410243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of deleterious functional effects of amino acid mutations using a library of structure-based function descriptors.
    Herrgard S; Cammer SA; Hoffman BT; Knutson S; Gallina M; Speir JA; Fetrow JS; Baxter SM
    Proteins; 2003 Dec; 53(4):806-16. PubMed ID: 14635123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations.
    Thusberg J; Vihinen M
    Hum Mutat; 2006 Dec; 27(12):1230-43. PubMed ID: 16986121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immuno-based detection assays to quantify distinct mutant huntingtin conformations in biological samples.
    Lotz GP; Weiss A
    Methods Mol Biol; 2013; 1017():163-71. PubMed ID: 23719915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. News from the protein mutability landscape.
    Hecht M; Bromberg Y; Rost B
    J Mol Biol; 2013 Nov; 425(21):3937-48. PubMed ID: 23896297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of disease-causing missense mutations.
    Stefl S; Nishi H; Petukh M; Panchenko AR; Alexov E
    J Mol Biol; 2013 Nov; 425(21):3919-36. PubMed ID: 23871686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of the influences of missense mutations on cholesteryl ester transfer protein structure.
    Dergunov AD
    Arch Biochem Biophys; 2014 Dec; 564():67-73. PubMed ID: 25201589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of pathogenicity in human MSH2 missense mutants.
    Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
    Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoimaging for protein misfolding diseases.
    Lyubchenko YL; Kim BH; Krasnoslobodtsev AV; Yu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):526-43. PubMed ID: 20665728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.